Juergen Wagner

858 total citations
18 papers, 671 citations indexed

About

Juergen Wagner is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Juergen Wagner has authored 18 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Oncology. Recurrent topics in Juergen Wagner's work include Retinoids in leukemia and cellular processes (4 papers), Pregnancy and preeclampsia studies (3 papers) and Signaling Pathways in Disease (3 papers). Juergen Wagner is often cited by papers focused on Retinoids in leukemia and cellular processes (4 papers), Pregnancy and preeclampsia studies (3 papers) and Signaling Pathways in Disease (3 papers). Juergen Wagner collaborates with scholars based in Germany, Switzerland and Austria. Juergen Wagner's co-authors include Detlev Ganten, Eberhard Ritz, Matthias Schaier, Joerg Kallen, Gerhard Zenke, Richard Sedrani, Michael Kaling, Randall E. Morris, Samuel Hintermann and Christoph Burkhart and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Kidney International.

In The Last Decade

Juergen Wagner

18 papers receiving 652 citations

Peers

Juergen Wagner

IMMUN

CCM

ONCOL

EDM

Rivka Hadar Israel

Julie L. Batista United States

Traci Marin United States

Pravin Rao United States

Hátylas Azevedo Brazil

Zahida Qamri United States

Rubben Torella United Kingdom

J. Wadsworth United Kingdom

Samuel T. Nadler United States

Hai-Lian Bi China

Rivka Hadar Israel

Juergen Wagner

312 ×1.1

108 ×0.7

IMMUN

15 ×0.1

CCM

139 ×1.8

ONCOL

84 ×1.2

EDM

Citations per year, relative to Juergen Wagner Juergen Wagner (= 1×) peers Rivka Hadar

Countries citing papers authored by Juergen Wagner

Since Specialization

Citations

This map shows the geographic impact of Juergen Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Wagner more than expected).

Fields of papers citing papers by Juergen Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Wagner. The network helps show where Juergen Wagner may publish in the future.

Co-authorship network of co-authors of Juergen Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Wagner. A scholar is included among the top collaborators of Juergen Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Wagner. Juergen Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Carcache, David A., Anna Vulpetti, Joerg Kallen, et al.. (2018). Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model. Journal of Medicinal Chemistry. 61(15). 6724–6735. 18 indexed citations

Eis, Maurice J. van, Jean-Pierre Evenou, W. Schüler, et al.. (2017). Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-α/β. Bioorganic & Medicinal Chemistry Letters. 27(4). 781–786. 11 indexed citations

Hintermann, Samuel, Christine Guntermann, Henri Mattes, et al.. (2016). Synthesis and Biological Evaluation of New Triazolo‐ and Imidazolopyridine RORγt Inverse Agonists. ChemMedChem. 11(24). 2640–2648. 20 indexed citations

Betschart, Claudia, Samuel Hintermann, Dirk Behnke, et al.. (2013). Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia. Journal of Medicinal Chemistry. 56(19). 7590–7607. 86 indexed citations

Eis, Maurice J. van, Jean-Pierre Evenou, Philipp Floersheim, et al.. (2011). 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes. Bioorganic & Medicinal Chemistry Letters. 21(24). 7367–7372. 27 indexed citations

Gruber, Thomas, Natascha Hermann‐Kleiter, Christa Pfeifhofer‐Obermair, et al.. (2009). PKCθ cooperates with PKCα in alloimmune responses of T cells in vivo. Molecular Immunology. 46(10). 2071–2079. 40 indexed citations

Weckbecker, Gisbert, Charles Pally, Christian Beerli, et al.. (2009). Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720. Transplant International. 23(5). 543–552. 27 indexed citations

Skvara, Hans, Markus Dawid, Barbara Wolff, et al.. (2008). The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. Journal of Clinical Investigation. 118(9). 3151–3159. 128 indexed citations

Kallen, Joerg, Richard Sedrani, Gerhard Zenke, & Juergen Wagner. (2005). Structure of Human Cyclophilin A in Complex with the Novel Immunosuppressant Sanglifehrin A at 1.6 Å Resolution. Journal of Biological Chemistry. 280(23). 21965–21971. 39 indexed citations

10.

Schaier, Matthias, Fujio Shimizu, Hiroshi Kawachi, et al.. (2004). Retinoic acid receptor ? and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. Journal of Molecular Medicine. 82(2). 116–125. 41 indexed citations

11.

Schaier, Matthias, et al.. (2003). Retinoid Agonist Isotretinoin Ameliorates Obstructive Renal Injury. The Journal of Urology. 170(4 Part 1). 1398–1402. 25 indexed citations

12.

Schaier, Matthias, et al.. (2002). Retinoid receptor-specific agonists alleviate experimental glomerulonephritis. American Journal of Physiology-Renal Physiology. 282(4). F741–F751. 58 indexed citations

13.

Wagner, Juergen. (2001). Potential role of retinoids in the therapy of renal disease. Nephrology Dialysis Transplantation. 16(3). 441–444. 18 indexed citations

14.

Wagner, Juergen, et al.. (1995). Transgenic Animals as Models for Human Disease. Clinical and Experimental Hypertension. 17(4). 593–605. 20 indexed citations

15.

Kreutz, Reinhold, Shokei Kim, Martina Schinke, et al.. (1995). Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin???angiotensin-system gene expression and cardiovascular functions. Journal of Hypertension. 13(8). 891–899. 89 indexed citations

16.

Wagner, Juergen, et al.. (1994). PCR analysis of human renal biopsies—Renin gene regulation in glomerulonephritis. Kidney International. 46(6). 1542–1545. 6 indexed citations

17.

Bachmann, J., et al.. (1993). Modulation of blood pressure and the renin-angiotensin system in transgenic and spontaneously hypertensive rats after ovariectomy. Journal of Hypertension. 11(5). S226???S227–S226???S227. 13 indexed citations

18.

Bäder, Michael, et al.. (1992). Basic methodology in the molecular characterization of genes. Journal of Hypertension. 10(1). 9–16. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact